Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01624155 · ClinicalTrials.gov registry record · NA
Increasing Contraception Utilization Among Women Prescribed Teratogenic Medications
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT01624155 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 33 participants.
The verdict
NCT01624155, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
Typically, the CTIS Pregnancy Health Information Line in the Department of Pediatrics, School of Medicine at the University of California educates pregnant women who call the Information Line after an exposure to a medication that might be harmful to the developing baby has already taken place, and therefore the opportunity for prevention of that exposure no longer exists. Frequently these pregnancies are unintended and occur due to the lack of effective contraceptive use. This study facilitates patient access at UCSD to specialized and individualized contraceptive counseling for women of reproductive age who are currently taking a medication that might be risky in a future pregnancy. This study also measures the impact of individualized contraceptive counseling in changing contraceptive behavior. Primary Hypothesis: EPIC (EMR)/physician-facilitated referral of female patients of reproductive age to an existing specialized counseling service at UCSD will improve the utilization of more effective contraception among women of reproductive age who are prescribed medications that might be harmful to the developing fetus.
Interventions
- BEHAVIORAL Education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2012-01-05 |
| Est. Completion | 2015-09-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01624155
The ClinicalTrials.gov registry entry for NCT01624155 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Education is the first listed.
NCT01624155 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01624155 about?
NCT01624155 is a clinical study titled "Increasing Contraception Utilization Among Women Prescribed Teratogenic Medications". Typically, the CTIS Pregnancy Health Information Line in the Department of Pediatrics, School of Medicine at the University of California educates pregnant women who call the Information Line after an exposure to a medication that might be harmful to the developing baby has already taken place, and ...
What is the current status of trial NCT01624155?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2012-01-05. Estimated completion is 2015-09-22.
What interventions are being tested in trial NCT01624155?
The interventions under investigation include: Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT01624155?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.